| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000234945.3 |
Ponatinib |
Brain lower grade glioma |
0.022970176 |
Resistant |
| ENSG00000234945.3 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003720655 |
Sensitive |
| ENSG00000234945.3 |
Ponatinib |
Esophageal cancer |
0.027998624 |
Resistant |
